Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation
about
Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleedingSystematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.Outcomes in the management of atrial fibrillation: clinical trial results can apply in practiceAnticoagulation in the elderlyReview article: gastrointestinal bleeding with low-dose aspirin - what's the risk?Ocular bleeding related to warfarin anticoagulation in patients with mechanical heart valve and atrial fibrillationEffects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis.Measurement of bleeding severity: a critical review.Warfarin therapy: in need of improvement after all these years.Using anticoagulation or aspirin to prevent stroke. Research was methodologically flawed.Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Clinical utilization of the international normalized ratio (INR).Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Patent foramen ovale and cryptogenic cerebral infarction.Atrial fibrillation in the elderly--an increasing problem that mandates aggressive management.Genetic determinants of response to warfarin during initial anticoagulationAssociation between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.Bleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management.Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.An automated database case definition for serious bleeding related to oral anticoagulant use.Interaction of warfarin with drugs, natural substances, and foods.Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect.Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.Frequency of adverse events in patients with poor anticoagulation: a meta-analysisEthnic differences in warfarin maintenance dose requirement and its relationship with genetics.The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis.Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.The business case for quality improvement: oral anticoagulation for atrial fibrillation.Upper Digestive Bleeding in Atrial Fibrillation: Evaluation of Gastroscopy Prior to Oral Anticoagulant Therapy (GOAT), Prospective, Randomized, Double Blind Study on a Community Population.Preventing cardioembolic stroke in atrial fibrillation with dabigatran.Current anticoagulant safety.Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum Beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact.Drug adherence in patients taking oral anticoagulation therapy.Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis.Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.Intracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke.Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.A prospective study on the use of warfarin in the United arab emirates.
P2860
Q24647605-932EEE33-7616-40AB-BD80-E0320C7F126FQ27337981-AB7A3649-A8C1-436B-990C-97C57EEE531CQ28188553-7776F511-E181-4D56-8E60-F62A8E62D535Q28196884-100BBD68-1483-4D49-A1DC-ABD6FBBEE184Q28200403-FE61C988-D673-4A85-8651-26B42495AE30Q28222062-FCE39785-A6D7-4BB4-941B-4215632FAAC3Q28364493-B65C6C55-96C7-4F0C-9618-D8A49E0F6D0BQ33360118-13101324-6743-40CC-8C16-3B9AC17A15C0Q33793086-59A4DB5A-6E2D-4C0C-9FB6-178DBB9717A9Q33800650-D71DF3FE-D316-4078-B9BF-751F30FF5EB8Q33891646-DDC7CB6F-03FE-40B7-A8AF-CF4B83BE9F67Q33910636-026598DC-4BA4-4825-B0DC-A5D8B27198C7Q34132273-3C4075CB-8282-44E3-87CA-99888B59C8F4Q34233473-AEDF9690-85D8-4CA2-8909-4FA87F1CCEE2Q34322413-E3E1803A-E94A-429E-8B18-B1D3B18B85D6Q34350281-1E808F7A-5331-4714-8A44-BBC4C2AE1716Q34759038-59FA58D8-1346-46B6-9EBA-09C598C856B8Q35016262-B6563787-7165-4A18-9520-96A71F96EC89Q35093560-1DCDAEF3-4B63-4CDF-A31A-74FEE691FAFFQ35878355-7E86E469-5BDA-4193-B876-0531DF2C4C3BQ35938914-66B5E9EE-A926-43A1-9055-936FC113287AQ36002461-E9ECB870-8EC7-428F-BCBA-59387E7465ADQ36007599-DDA00103-3644-485D-881D-AE21A3EEF179Q36112764-FE419EBD-3A5F-4527-9617-BB2C1259E868Q36341724-9AE43028-B641-4B6B-AE56-F94C7EF2FB63Q36827674-D669841B-D8C2-44EF-B123-8B2F7E76B9D0Q37264555-9436D187-D889-4336-8398-93997BFDB2EAQ37333837-F128D3C2-AA3B-4AC8-96DA-0A7AAD3A86D7Q37464600-1BEF8D99-0F69-42F1-9B49-7C252885E8E7Q37666333-94D54505-359D-473A-B85C-05534FCB48D5Q37711335-07D9DA73-EDD5-4D9F-A9A4-23E9A3C5799EQ37940877-31AE2722-7FDC-4381-AEF0-7361AA482F05Q37990564-6B2D22AC-0DB8-425A-8CDE-957306DE96E3Q38086826-59E32433-5FB2-4345-9B6C-55D9B457D3A8Q38133767-EDB96643-3D6E-4BA9-A1C2-05F7BE9F1EC5Q38224507-0246AE64-D328-4985-836A-3D55CD22E910Q38942382-AC1BCDED-4562-4A63-93BE-FBD837E941BEQ39962487-ED3B7781-02A3-4889-8547-5CA1854AD12AQ40597502-3D34A23E-AA54-439C-B3CD-A073144EAFE5Q41908505-F485C437-6D26-4CAA-AFEA-518041779011
P2860
Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@ast
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@en
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@nl
type
label
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@ast
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@en
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@nl
prefLabel
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@ast
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@en
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@nl
P2093
P921
P3181
P1476
Bleeding during warfarin and a ...... on Aspirin and Anticoagulation
@en
P2093
A L Gulløv
B G Koefoed
P Petersen
P304
P3181
P356
10.1001/ARCHINTE.159.12.1322
P407
P577
1999-06-28T00:00:00Z